Posters
« Back
Colonic Stenting in Mid-Yorkshire Hospitals NHS Trust: Are we doing it appropriately?
EP30577
Poster Title: Colonic Stenting in Mid-Yorkshire Hospitals NHS Trust: Are we doing it appropriately?
Submitted on 20 Sep 2019
Author(s): Claire Ryan; Stuart Kerr
Affiliations: Mid-Yorkshire Hospitals NHS Trust
Poster Views: 246
View poster »


Poster Information
Abstract: Background: Colorectal cancer was the 3rd most diagnosed cancer worldwide in 2018 (1.8M cases)[1]. Large bowel obstruction (LBO) has been shown to occur in around 8% of stage IV colon cancers[2]. The treatment approach of acute LBO remains controversial - whether by self-expandable metallic stents or surgical intervention[3]. The European Society of Gastrointestinal Endoscopy (ESGE) and National Institute for Health and Care Excellence (NICE) have guidelines[4,5] regarding colonic stents: generally, their indication is for palliative treatment of malignant left-sided LBO.

Aims: To investigate whether we, at Mid-Yorkshire Hospitals, are stenting appropriate patients, observe our complication rate and review our survival data.

Methods: We undertook a retrospective analysis, gathering data from all patients stented between January 2014 - December 2018, using the trust's colonic stent database (populated by the radiologists performing these procedures) and the Radiology Information System (CRIS).

Results: There were 118 patients (142 procedures: 15% had repeat stents); age range: 39-92; 46 females, 72 males. 84% of patients were palliative. Of all procedures, 64 were for acute LBO and 78 were elective (outpatient or ‘prophylactic’; 45% v 55%). 21% led to an early complication (within 2 weeks) and 25% resulted in a late complication. Median survival was approximately 9 months.


Conclusions: It appears most patients are appropriately selected for colonic stenting, with complication rates comparable with published studies. Stenting should only be performed in patients with evidence of obstruction and not as a prophylactic procedure. Stenting as a “bridge to surgery” in non-palliative patients is controversial, in light of the adverse oncological implications of iatrogenic perforation.
Summary: Colonic Stenting in Mid-Yorkshire Hospitals NHS Trust: Are We Doing it Appropriately?References: 1. Bray F, Ferlay J et al Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424
2. Winner M, Mooney SJ, Hershman DL et al. Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. JAMA Surg 2013; 148: 715–722
3. Hill J et al Randomised phase III study of stenting as a bridge to surgery in obstructing colorectal cancer-Results of the UK ColoRectal Endoscopic Stenting Trial (CREST). J CLIN ONCOL 2016; 34(15): 3507-3507
4. van Hooft Jeanin E et al. SEMSs for obstructing colonic and extracolonic cancer: ESGE Clinical Guidelines. Endoscopy 2014; 46: 990-1002
5. NICE Evidence review. CG131 Colorectal cancer: the diagnosis and management of colorectal cancer. Ch 3.2 Colonic Stents. 2011: 230-238.
6. Iverson, et al Self-expanding metallic stents as a bridge to surgery in obstructing colorectal cancer. B
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


The Ebola Virus: Community Awareness
SAMBASIVARAO YARAGALLA, Navami Guru, Dagbue Sophia, Hernandez Aleyda San, Kamal sepla, Alrashid Zaid Arkan, Daniel Cheong, Abhinaya Murali, Chelsea Dilsuk, Khushal Alete, Savin Peter, Badrinarayana Ajay Maharaj

Public Responsibilities to fight COVID19
Ramesh Vithoba Shinde

ANTIMICROBIAL ACTIVITY OF NEWER DISINFECTANT ON MULTIDRUG RESISTANCE ORGANISMS IN ST.LUCIA
DR. SAMBASIVARAO YARAGALLA, DHRUV PATEL,MEET PATEL, OKUNLOLA OLUWASEMILORE I , CHUKWUEBUNI ONYEBUCHI HANNAH, IJEOMA NWABUOKEI

HRCT PATTERN IN USUAL INTERSTITIAL PNEUMONIA
Dr Azim Ilyas

Bells Palsy management Re-audit
Waqas Jamil